EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study

Laura N Walti iD, Chun Fai Ng iD, Simran Kaur, Sarah Almansour, Tony Mazzulli iD, Roni Bitterman iD, Aman Sidhu iD, Shaf Keshavjee iD, Cecilia Chaparro iD, Tereza Martinu iD, Jussi Tikkanen iD, Lorenzo Del Sorbo iD und 1 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf078 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Laura N Walti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Infectious Diseases, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Hyperammonemia, Ammonia, Lung Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: postdoctoral, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperammonemia syndrome (HS) is a rare but potentially fatal complication of lung transplantation (LT). Optimal screening methods are unknown. Here we investigated serum ammonia screening (SAS) for HS and compared it with polymerase chain reaction (PCR) for Mollicutes (Urease-producing bacteria).

Methods

All LT recipients from July 2019 to February 2020 and October 2021 to November 2022 with available donor bronchial wash samples from the LT biobank were included. Mollicutes PCR was performed using 2 commercially available kits. Daily ammonia serum levels were measured for the first 14 days. Recipients were prospectively followed for HS for 30 days post-LT. HS was defined by new neurological symptoms and the presence of elevated serum ammonia (>1 × >70 µmol/L).

Results

Of 241 LT recipients, 5 (2%) developed HS within the first month post-LT. Median time to HS was 8 (interquartile range, 5–10) days. All HS was diagnosed within the first 14 days post-LT, while daily SAS was in place. Ammonia was confirmed elevated (>1 × >70 µmol/L) in 4% (9/241) during follow-up; however, outside of HS, 4 were found to be related to liver disease. Donor and recipient Mollicutes PCR was positive in 8% (19/241) and 1% (1/72), respectively, at transplant. Donor Mollicutes PCR, in contrast to recipient Mollicutes PCR, was associated with HS but only in 2 of the 5 HS cases. No HS patient died within 90 days post-LT.

Conclusions

HS was a rare complication in our LT cohort. Daily post-LT SAS might add to early HS diagnosis and treatment and is potentially associated with improved outcome. Donor screening with Mollicutes PCR has limited predictive value for HS post-LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperammonemiaAmmoniaLung TransplantationHumansMaleFemaleProspective StudiesMiddle AgedTissue DonorsAgedAdultPolymerase Chain Reaction

Stichwörter der Autor:innen

Mollicuteshyperammonemia syndromelung transplantationserum ammonia screeningtransplant infectious diseases

Substanzen

Ammonia

Autor:innen und Institutionen

  • Transplant Infectious Diseases, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Microbiology, Mount Sinai Hospital and University Health Network, Toronto, Ontario, Canada.
  • Toronto Lung Transplant Program, Ajmera Transplant Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Division of Respirology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Laura N Walti, Chun Fai Ng, Tony Mazzulli, Roni Bitterman, Aman Sidhu, Shaf Keshavjee, Cecilia Chaparro, Tereza Martinu, Jussi Tikkanen, Lorenzo Del Sorbo, Shahid Husain

Förderung

  • postdoctoral
  • Swiss National Science Foundation

Zitieren

APA

Walti, L. N., Ng, C. F., Kaur, S., Almansour, S., Mazzulli, T., Bitterman, R., Sidhu, A., Keshavjee, S., Chaparro, C., Martinu, T., Tikkanen, J., Del Sorbo, L., & Husain, S. (2025). Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf078

Vancouver

Walti LN, Ng CF, Kaur S, Almansour S, Mazzulli T, Bitterman R, et al. Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf078

BibTeX
@article{Walti2025,
  author = {Walti, Laura N and Ng, Chun Fai and Kaur, Simran and Almansour, Sarah and Mazzulli, Tony and Bitterman, Roni and Sidhu, Aman and Keshavjee, Shaf and Chaparro, Cecilia and Martinu, Tereza and Tikkanen, Jussi and Del Sorbo, Lorenzo and Husain, Shahid},
  title = {Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf078}
}
Kostenlos starten →